Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience

Aref Al-Kali, Ahmed Kamel Abou Hussein, Mrinal M Patnaik, Darci Zblewski, Naseema Gangat, Shahrukh Hashmi, Michelle Elliott, William Hogan, Mark R Litzow

Research output: Contribution to journalArticlepeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalLeukemia and Lymphoma
StateAccepted/In press - Feb 22 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this